NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 658837 | Null | 0.0392716453377535 | -0.051679199 |
NSC 664701 | Null | 0.0392716453377535 | 0.34928761 |
NSC 686554 | 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- | 0.0392716453377535 | 0.33350675 |
NSC 693169 | Null | 0.0392716453377535 | -0.087457381 |
NSC 699934 | Null | 0.0392716453377535 | 0.38189292 |
NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.0392716453377535 | 0.0065175987 |
NSC 717953 | Null | 0.0392716453377535 | -0.1572066 |
NSC 718630 | Null | 0.0392716453377535 | 0.030352866 |
NSC 720497 | Null | 0.0392716453377535 | -0.040626944 |
NSC 726217 | Combretastatin A4-analogue | 0.0392716453377535 | -0.030346072 |